Study: Jafari 2025, Pharmacological Research
Does Nigella sativa supplementation improve cardiovascular disease risk factors? A comprehensive GRADE-assessed systematic review and dose-response meta-analysis of 82 randomized controlled trials
Citation
Jafari A, Mardani H, Faghfouri AH, Fashtali ZM et al (2025). Pharmacological Research. PubMed id 40714301.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Black seed oil (Nigella sativa) Tier B moderate
B 82 studies (79 quantitative and 3 qualitative; the title calls them randomised controlled trials), 5,026 participants, 1 to 48 weeks (doses 200 to 4,600 mg a day) (n=5026)
Systematic review and dose-response meta-analysis, GRADE-assessed.
Nigella sativa supplementation significantly improved body fat percentage, systolic blood pressure, mean arterial pressure, fasting blood sugar, HbA1c, post-meal glucose, insulin sensitivity, C-reactive protein, cholesterol fractions and triglycerides. The authors conclude it could be a promising adjunct therapy for improving cardiovascular risk factors.
As recorded in this card: Jafari A, Mardani H, Faghfouri AH, Fashtali ZM et al (2025), Pharmacological Research, [review]
Note: The abstract does not give the certainty grade or participants' ancestry; no safety summary read. Authors report no competing interests.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.